KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 107 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q4 2014. The put-call ratio across all filers is 12.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $30,149,000 | -52.1% | 402,209 | -51.9% | 0.00% | -42.9% |
| Q2 2015 | $62,975,000 | +78.7% | 836,191 | +19.0% | 0.01% | +75.0% |
| Q1 2015 | $35,232,000 | +39.4% | 702,581 | -3.6% | 0.00% | +33.3% |
| Q4 2014 | $25,273,000 | +16.7% | 728,816 | +10.2% | 0.00% | +50.0% |
| Q3 2014 | $21,664,000 | -10.6% | 661,370 | +4.7% | 0.00% | -33.3% |
| Q2 2014 | $24,230,000 | +8.9% | 631,392 | +12.8% | 0.00% | 0.0% |
| Q1 2014 | $22,257,000 | -0.2% | 559,731 | -8.1% | 0.00% | +200.0% |
| Q4 2013 | $22,307,000 | +275.7% | 609,282 | +369.0% | 0.00% | 0.0% |
| Q3 2013 | $5,938,000 | +194.0% | 129,903 | +73.8% | 0.00% | – |
| Q2 2013 | $2,020,000 | – | 74,746 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 1,810,518 | $71,986,000 | 2.98% |
| Redmile Group, LLC | 443,326 | $17,627,000 | 2.10% |
| AlpInvest Partners B.V. | 22,224 | $884,000 | 2.04% |
| SENZAR ASSET MANAGEMENT, LLC | 89,500 | $3,558,000 | 1.88% |
| Aureus Asset Management, LLC | 136,305 | $5,419,000 | 1.39% |
| PFM Health Sciences, LP | 1,003,492 | $39,899,000 | 0.72% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $7,016,000 | 0.68% |
| Ghost Tree Capital, LLC | 25,000 | $994,000 | 0.59% |
| HAMILTON LANE ADVISORS LLC | 30,264 | $1,203,000 | 0.48% |
| Pentwater Capital Management LP | 390,000 | $15,506,000 | 0.41% |